BioMarin Pharmaceuticals, Inc. (BMRN) Misses Q1 EPS by 2c
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) reported Q1 EPS ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
